Publications 2011

Babin E, Blanchard D, Hitier M. Management of total laryngectomy patients over time: from the consultation announcing the diagnosis to long term follow-up. Eur Arch Otorhinolaryngol. 2011 Oct;268(10):1407-19. Epub 2011 Jun 26.

———————————————————————————————————————————————————

Baldi I, Coureau G, Jaffré A, Gruber A, Ducamp S, Provost D, Lebailly P, Vital A, Loiseau H, Salamon R. Occupational and residential exposure to electromagnetic fields and risk of brain tumors in adults: A case-control study in Gironde, France. Int J Cancer. 2011;129:1477-84.

———————————————————————————————————————————————————

Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A, Tourdias T, Kantor G, Maire JP, Vital A, Loiseau H; Gironde TSNC Registry Group. Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro Oncol 2011 13(12):1370-8.

———————————————————————————————————————————————————

Baldi I, Gruber A, Rondeau V, Lebailly P, Brochard P, Fabrigoule C. Neurobehavioral effects of long-term exposure to pesticides: results from the 4-year follow-up of the PHYTONER study. Occup Environ Med. 2011;68:108-15.

———————————————————————————————————————————————————

Beau-Faller M, Degeorges A, Rolland E, Mounawar M, Antoine M, Poulot V, Mauguen A, Barbu V, Coulet F, Prétet JL, Bièche I, Blons H, Boyer JC, Buisine MP, de Fraipont F, Lizard S, Olschwang S, Saulnier P, Prunier-Mirebeau D, Richard N, Danel C, Brambilla E, Chouaid C, Zalcman G, Hainaut P, Michiels S, Cadranel J.Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project–part 1). J Thorac Oncol. 2011 Jun;6(6):1006-15

———————————————————————————————————————————————————

Belot A, Remontet L, Launoy G, Jooste V, Giorgi R, and the French network of cancer registries FRANCIM.Competing risks models to estimate the excess mortality and the first recurrent-event hazards. BMC Medical Research Methodology. BMC Med Res Methodol. 2011 May 25;11(1):78

———————————————————————————————————————————————————

Berchi C, Launoy G. CRC screening- cost effectiveness of fecal immunochemical tests. Nature Reviews Gastroenterology & Hepatology 2011 ; Dec 5;8(12):663-4.

———————————————————————————————————————————————————

Bergot E, Levallet G, Creveuil C, Lechapt E, Zalcman G. [Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues]. Presse Med. 2011 Apr;40(4 Pt 1):379-88.

———————————————————————————————————————————————————

Besse B, Zalcman G. [What is the best sequence of treatment for patients with EGFR mutations?]. [Article in French] Rev Pneumol Clin. 2011 Jun;67 Suppl 1:S24-9.

———————————————————————————————————————————————————

Blanchard D, Choussy O, Rame J, Bequigon A, Dehesdin D, De Raucourt D, Bardet S, Babin E. [Thyroid differenciated carcinoma in children. Study from Normandy]. Rev Laryngol Otol Rhinol (Bord). 2011;132(4-5):197-201.

———————————————————————————————————————————————————

Bridoux V, Kianifard B, Moutel G, Herve C, Tuech JJ. Stenting as a bridge to surgery for colorectal cancer. Lancet Oncol. 2011 Jul;12(7):621; author reply 621-2.

———————————————————————————————————————————————————

Buiret G, Launoy G, Remontet L, Bossard N, Iwaz J, Belot A, Ecochard R. Diversité des modèles d’évolution des incidences : implication en cancérogenèse. Rev Mal Respir. 2011 Jan;28(1):41-50.

———————————————————————————————————————————————————

Cadranel J, Zalcman G, Sequist L. Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer. Eur Respir J. 2011 Jan;37(1):183-93.

———————————————————————————————————————————————————

Caravati-Jouvenceaux A, Launoy G, Klein D, Henry-Amar M, Abeilard E, Danzon A, Pozet A, Velten M, Mercier M. Health-related quality of life among long-term survivors of colorectal cancer: a population-based study. Oncologist 2011;16(11):1626-1636.

———————————————————————————————————————————————————

Castrale C, El Haggan W, Chapon F, Reman O, Lobbedez T, Ryckelynck JP, Hurault de Ligny B. . Lymphomatoid granulomatosis treated successfully with rituximab in a renal transplant patient. J Transplant. 2011;2011:865957

———————————————————————————————————————————————————

Ciappuccini R, Heutte N, Trzepla G, Rame J-P, Vaur D, Aide N, Bardet S. Postablation 131I scintigraphy with neck and thorax SPECT-CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer. European Journal of Endocrinology. 2011; 164(6) :961-9.

———————————————————————————————————————————————————

Clin B, Luc A, Morlais F, Paris C, Ameille J, Brochard P, De Girolamo J, Gislard A, Laurent F, Letourneux M, Schorle E, APEXS members, Launoy G, Pairon JC. Pulmonary nodules detected by thoracic CT scan during medical surveillance after exposure to asbestos: diagnostic significance. Int J Tubercul and Lung Disease, 2011,15(12), 1707-1713

———————————————————————————————————————————————————

Clin B, Morlais F, Guizard AV, Dubois B, Bouvier V, Guittet L, Désoubeaux N, Marquignon MF, Raffaelli C, Paris C, Galateau-Sallé F, Launoy G, Letourneux M. Cancer incidence within a cohort occupationally exposed to asbestos: study of dose-response relationships. Occup Environ Med, 2011;68(11):832-836.

———————————————————————————————————————————————————

Clin B, Paris C, Ameille J, Brochard P, Conso F, Gislard A, Laurent F, Letourneux M, Luc A, Schorle E, Pairon JC. Pleural plaques observed on HCRT and lung function in asbestos-exposed workers free from pulmonary fibrosis. Thorax, 2011;66(11):985-991.

———————————————————————————————————————————————————

Covic A, Bammens B, Lobbedez T, Segall L, Heimbürger O, van Biesen W, Fouque D, Vanholder R. Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant. 2010 Jun;25(6):1757-9.

———————————————————————————————————————————————————

Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, Lebailly P, Fabbro-Peray P, Baldi I. Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control. 2011;22:697-714.

———————————————————————————————————————————————————

Cremer R, Hubert P, Grandbastien B, Moutel G, Leclerc F; GFRUP’s study group on forgoing treatments. Prevalence of questioning regarding life-sustaining treatment and time utilisation by forgoing treatment in francophone PICUs. Intensive Care Med. 2011 Oct;37(10):1648-55. 16.

———————————————————————————————————————————————————

Culine S, Flechon A, Guillot A, Le Moulec S, Pouessel D, Rolland F, Ravaud A, Houede N, Mignot L, Joly F, Oudard S, Gourgou S. Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group (GETUG V01). Eur Urol 2011;60(6):1251-7.

———————————————————————————————————————————————————

Dejardin O, Berchi C, Mignon A, Pornet C, Guillaume E, Guittet L, Bouvier V, Sailly M, Salinas A, Christophe V, Launoy G. [Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?]. Rev Epidemiol Sante Publique. 2011;59:45-51.

———————————————————————————————————————————————————

Dejardin O, Ruault E, Jooste V, Pornet C, Bouvier V, Bouvier AM, Launoy G. Volume of surgical activity and lymph node evaluation for patients with colorectal cancer in France. Dig Liver Dis. 2011 Nov 23. PMID: 22119218

———————————————————————————————————————————————————

Demiselle J, Lheureux S, Clarisse B, Sevin E, Joly F. Metastatic renal cancer: evolution of five complete response cases after the  antiangiogenic discontinuation. Bull Cancer. 2011 Jun 9.

———————————————————————————————————————————————————

Dupont-Lucas C, Dejardin O, Dancourt V, Launay L, Launoy G, Guittet L. Socio-geographical determinants of colonoscopy uptake after faecal occult blood test. Dig Liver Dis. 2011;43:714-20.

———————————————————————————————————————————————————

Fafin-Lefevre M, Morlais F, Guittet L, Clin B, Launoy G, Galateau-Sallé F, Plancoulaine B, Herlin P, Letourneux M. Nuclear morphology for the detection of alterations in bronchial cells from lung cancer: an attempt to improve sensitivity and specificity. Anal Quant Cytol Histol. 2011;33:183-95.

———————————————————————————————————————————————————

Ferrant O, Papin F, Clin B, Lacroix C, Saussereau E, Remoué JE, Goullé JP. Fatal poisoning due to snorting buprenorphine and alcohol consumption. Forensic Sci Int. 2011 Jan 30;204(1-3):e8-11.

———————————————————————————————————————————————————

Ficheux M, Cuny P, Lecouf A, Ryckelynck JP, Hurault de Ligny B, Lobbedez T. [Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis] [Article in French] Nephrol Ther. 2011 Dec;7(7):558-6

———————————————————————————————————————————————————

Flechon A, Pouessel D, Ferlay C, Perol D, Beuzeboc P, Gravis G, Joly F, Oudard S, Deplanque G, Zanetta S, Fargeot P, Priou F, Droz Jp, Culine S. Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial. Ann Oncol 2011;22(11):2476-81.

———————————————————————————————————————————————————

Franrenet S, Moutel G, Raffi F, Dabis F, Bruyand M, Hervé C, Leport C, Duchange N. Information that should be given to HIV cohort participants during ongoing research: the viewpoints of patient representatives and research professionals. J Empir Res Hum Res Ethics. 2011 Dec;6(4):76-83.

———————————————————————————————————————————————————

Gancel PE, Roupie E, Guittet L, Laplume S, Terzi N. Accuracy of a transcutaneous carbon dioxide pressure monitoring device in emergency room patients with acute respiratory failure. Intensive Care Med. 2011 Feb;37(2):348-51.

———————————————————————————————————————————————————

Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, Otter R, Licitra L, Mallone S, Tavilla A, Trama A, Capocaccia R; RARECARE working group. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011 Nov;4 (17):2493-511.

———————————————————————————————————————————————————

Grimbert I, Guittet L, Demichelis F, Després P. [The needs of elderly or disabled inmates in Basse-Normandie]. [Article in French] Soins Gerontol. 2011 Mar-Apr;(88):34-7.

———————————————————————————————————————————————————

Gueutin V, Ficheux M, Châtelet V, Lecouf A, Henri P, Hurault de Ligny B, Ryckelynck JP, Lobbedez T. Hydration status of patients with end-stage renal disease after kidney transplantation. Clin Transplant. 2011 Nov-Dec;25(6):E656-63.

———————————————————————————————————————————————————

Guittet L, Bailly L, Bouvier V, Launoy G. Indirect comparison of performances of two quantitative immunochemical faecal occult blood tests in average-risk population. Journal of Medical Screnning. 2011;18(2):76-81.

———————————————————————————————————————————————————

Guittet L, Guillaume E, Bouvier V, Launoy G. Seasonal variations of immunochemical and gaiac faecal occult blood tests. GUT 2011 Mar;60(3):423-4.

———————————————————————————————————————————————————

Guittet L, Guillaume E, Levillain R, Beley P, Tichet J, Lantieri O, Launoy G. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2011;20:1492-501.

———————————————————————————————————————————————————

Heutte N, Haioun C, Feugier P, Coiffier B, Tilly H, Ferme C, Gabarre J, Morschhauser F, Gisselbrecht C, Mounier N for the GELA(Groupe d’Etude des Lymphomes de l’Adulte).Qualityof life in 269 poorrisk Diffuse Large B-cell Lymphoma patients treated with rituximab versus observation after autologous stem cell transplantation.Leukemia and Lymphoma. 2011; 52(7) :1239-48.

———————————————————————————————————————————————————

Jean D, Thomas E, Manié E, Renier A, de Reynies A, Lecomte C, Andujar P, Fleury-Feith J, Galateau-Sallé F, Giovannini M, Zucman-Rossi J, Stern MH, Jaurand MC. Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma. Am J Pathol. 2011 ; 178:881-94.

———————————————————————————————————————————————————

Joly F, Paciencia M, Bor C, Aide N. Postchemotherapy Residual Masses in Nonseminomatous Germ Cell Tumor Patients: 18F-FLT PET Is Unlikely to Identify Mature Teratoma, but Imaging of {alpha}v{beta}3 Integrin Expression Could. J Nucl Med 2011;52(5):840.

———————————————————————————————————————————————————

Joly F, Ray-Coquard I, Fabbro M, Donoghoe M, Boman K, Sugimoto A, Vaughan M, Reinthaller A, Vergote I, Ferrandina G, Dell’anna T, Huober J, Pujade-Lauraine E. Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial. Gynecol Oncol 2011;122(2):226-32.

———————————————————————————————————————————————————

Joly F, Rigal O, Noal S, Giffard B. Cognitive dysfunction and cancer: which consequences in terms of disease management? Psychooncology 2011;20(12):1251-8.

———————————————————————————————————————————————————

Joly F. Cancer du rein et fatigue : quels enjeux à l’ère des antiangiogéniques ? Bull Cancer 2011;98(9):1071-81.

———————————————————————————————————————————————————

Jooste V, Remontet L, Colonna M, Belot A, Launoy G, Binder F, Faivre J, Bouvier AM. Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010.Eur J Cancer Prev. 2011 Sep;20(5):375-80.

———————————————————————————————————————————————————

Klein D, Mercier M, Abeilard E, Puyraveau M, Danzon A, Dalstein V, Pozet A, Guizard AV, Henry-Amar M, Velten M. Long-term quality of life after breast cancer: a French registry-based controlled study. Breast Cancer Res Treat 2011;129(1):125-134.

———————————————————————————————————————————————————

Labombarda F, Pellissier A, Ellafi M, Creveuil C, Ribault V, Laurans M, Guillot M, Bergot E, Grollier G, Milliez P, Zalcman G, Saloux E. Myocardial strain assessment in cystic fibrosis. J Am Soc Echocardiogr. 2011 Sep;24(9):1037-45. IF:3,707

———————————————————————————————————————————————————

Lagrange Jl, Bascoul-Mollevi C, Geoffrois L, Beckendorf V, Ferrero Jm, Joly F, Allouache N, Bachaud Jm, Chevreau C, Kramar A, Chauvet B. Quality of Life Assessment After Concurrent Chemoradiation for Invasive Bladder Cancer: Results of a Multicenter Prospective Study (GETUG 97-015). Int J Radiat Oncol Biol Phys 2011;79(1):172-8.

———————————————————————————————————————————————————

Labombarda F, Pellissier A, Ellafi M, Creveuil C, Ribault V, Laurans M, Guillot M, Bergot E, Grollier G, Milliez P, Zalcman G, Saloux E. Myocardial strain assessment in cystic fibrosis. J Am Soc Echocardiogr. 2011 Sep;24(9):1037-45.

———————————————————————————————————————————————————

Lange M, Giffard B, Eustache F., Morel N., Noal S, Joly F. Impact de la chimiothérapie adjuvante dans le cancer du sein : revue de la littérature. Psycho-oncologie 2011 5(1); 3-10

———————————————————————————————————————————————————

Le Hello C, Fradin S, Morello R, Coffin O, Maïza D, Hamon M. Contribution of deletion in angiotensin-converting enzyme but not A1166C angiotensin II type-1 receptor gene polymorphisms to clinical outcomes in atherothrombotic disease.  Arch Med Res. 2011 Apr;42(3):202-10.

———————————————————————————————————————————————————

Le Naourès C, Bonhomme J, Terzi N, Duhamel C, Galateau-Sallé F. A fatal case with disseminated Myceliophthora thermophila infection in a lymphoma patient. Diagn Microbiol Infect Dis. 2011 Jun;70(2):267-9.

———————————————————————————————————————————————————

Leon ME, Beane Freeman LE, Douwes J, Hoppin JA, Kromhout H, Lebailly P, Nordby KC, Schenker M, Schüz J, Waring SC, Alavanja MC, Annesi-Maesano I, Baldi I, Dalvie MA, Ferro G, Fervers B, Langseth H, London L, Lynch CF, McLaughlin J, Merchant JA, Pahwa P, Sigsgaard T, Stayner L, Wesseling C, Yoo KY, Zahm SH, Straif K, Blair A. AGRICOH: a consortium of agricultural cohorts. Int J Environ Res Public Health. 2011;8:1341-57.

———————————————————————————————————————————————————

Lheureux S, Clarisse B, Launay-Vacher V, Gunzer K, Delcambre-Lair C, Bouhier Leporrier K, Kaluzinski L, Maron D, Ngo Md, Grossi S, Dubois B, Zalcman G, Joly F. Evaluation of current practice: management of chemotherapy-related toxicities. Anticancer Drugs 2011;22(9):919-25.

———————————————————————————————————————————————————

Ligier K, Belot A, Launoy G, Velten M, Bossard N, Iwaz J, Righini CA, Delafosse P, Guizard AV; network Francim. Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010. Oral Oncol. 2011 Apr;47(4):302-7.

———————————————————————————————————————————————————

Ligier K, Belot A, Launoy G, Velten M, Delafosse P, Guizard AV; le réseau FRANCIM. [Epidemiology of oral cavity cancers in France]. Rev Stomatol Chir Maxillo fac. 2011 Jun;112(3):164-71.

———————————————————————————————————————————————————

Loaëc M, Morinière S, Hitier M, Ferrant O, Plauchu H, Babin E. Psychosocial quality of life in hereditary haemorrhagic telangiectasia patients. Rhinology. 2011 Jun;49(2):164-7.

———————————————————————————————————————————————————

Lobbedez T, Touam M, Evans D, Ryckelynck JP, Knebelman B, Verger C. Peritoneal dialysis in polycystic kidney disease patients. Report from the French peritoneal dialysis registry (RDPLF). Nephrol Dial Transplant. 2011 Jul;26(7):2332-9.

———————————————————————————————————————————————————

Luce D, Stücker I; ICARE Study Group. Investigation of occupational and environmental causes of respiratory cancers (ICARE): a multicenter, population-based case-control study in France. BMC Public Health. 2011 Dec 14;11:928.

———————————————————————————————————————————————————

Mollo V, Pernet A, Moutel G, Duchange N, Giraud P. [Can or must the patient participate to risk management in radiotherapy?]. [Article in French] Cancer Radiother. 2011 Jun;15(3):176-81.

———————————————————————————————————————————————————

Montani D, Coulet F, Girerd B, Eyries M, Bergot E, Mal H, Biondi G, Dromer C, Hugues T, Marquette C, O’Connell C, O’Callaghan DS, Savale L, Jaïs X, Dorfmüller P, Begueret H, Bertoletti L, Sitbon O, Bellanné-Chantelot C, Zalcman G, Simonneau G, Humbert M, Soubrier F. Pulmonary hypertension in patients with neurofibromatosis type I. Medicine (Baltimore). 2011 May;90(3):201-11.

———————————————————————————————————————————————————

Neuzillet Y, Guy L, Long JA, Zini L, Chevreau C, Duclos B, Escudier B, Gimel P, Joly F, Lang H, Mejean A, Oudard S, Roumeguere T. [Case report of kidney cancer from JOUM 2010]. [Article in French] Prog Urol. 2011 Mar;21 Suppl 2:S27-33.

———————————————————————————————————————————————————

Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Ségura C, Collet F, Allouache D, Switsers O, Delcambre C, Delozier T, Henry-Amar M, Joly F. One-Year Longitudinal Study of Fatigue,Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2011; 81(3) :795803.

———————————————————————————————————————————————————

Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L; French Vasculitis Study Group. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum. 2010 Feb;62(2):616-26.

———————————————————————————————————————————————————

Peyro Saint Paul L, Albessard F, Gaillard C, Debruyne D, Ryckelynck JP, Coquerel A, Lobbedez T. Daptomycin compatibility in peritoneal dialysis solutions. Perit Dial Int. 2011 Jul-Aug;31(4):492-5.

———————————————————————————————————————————————————

Querleu D, Planchamp F, Narducci F, Morice P, Joly F, Genestie C, Haie-Meder C, Thomas L, Quénel-Tueux N, Daraï E, Dorangeon PH, Marret H, Taïeb S, Mazeau-Woynar V; Institut National du Cancer; Societe Francaise d’Oncologie Gynecologique. Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d’Oncologie Gynécologique. Int J Gynecol Cancer. 2011 Jul;21(5):945-50.

———————————————————————————————————————————————————

Quoix E, Westeel V, Zalcman G, Milleron B. Chemotherapy in elderly patients with advanced non-small cell lung cancer. Lung Cancer. 2011 Dec;74(3):364-8.

———————————————————————————————————————————————————

Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Bennouna J, Tredaniel J, Ducoloné A, Lebitasy MP, Baudrin L, Laporte S, Milleron B; Intergroupe Francophone de Cancérologie Thoracique. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet. 2011 Sep 17;378(9796):1079-88.

———————————————————————————————————————————————————

Ribeiro E, Cogez J, Babin E, Viader F, Defer G. Stroke in hereditary hemorrhagic telangiectasia patients. New evidence for repeated screening and early treatment of pulmonary vascular malformations: two case reports. BMC Neurol. 2011 Jul 9;11:84.

———————————————————————————————————————————————————

Rice D, Rusch V, Pass H, Asamura H, Nakano T, Edwards J, Giroux DJ, Hasegawa S, Kernstine KH, Waller D, Rami-Porta R; International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol. 2011 Aug;6(8):1304-12.

———————————————————————————————————————————————————

Rigaud JP, Quenot JP, Borel M, Plu I, Hervé C, Moutel G. Post mortem scientific sampling and the search for causes of death in intensive care: what information should be given and what consent should be obtained? J Med Ethics. 2011 Mar;37(3):132-6.

———————————————————————————————————————————————————

Robard L, Blanchard D, Babin E, Loaec M, Hitier M. [Esophageal foreign body: dental plate]. Rev Laryngol Otol Rhinol (Bord). 2011;132(4-5):251-4.

———————————————————————————————————————————————————

Rogel A, Belot A, Suzan F, Bossard N, Boussac M, Arveux P, Buémi A, Colonna M, Danzon A, Ganry O, Guizard AV, Grosclaude P, Velten M, Jougla E, Iwaz J, Estève J, Chérié-Challine L, Remontet L. Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri. Cancer Epidemiol. 2011 Jun;35(3):243-9.

———————————————————————————————————————————————————

Ryckelynck JP, Abbadie O, Castrale C, Lavainne F, Fakhouri F, Lobbedez T. [Why and how to promote peritoneal dialysis?]. [Article in French] Presse Med. 2011 Nov;40(11):1053-8.

———————————————————————————————————————————————————

Tredaniel J, Mornex F, Barillot I, Diaz O, Hennequin C, Le Pechoux C, Lavole A, Giraud P, Souquet PJ, Teixeira L, Vaylet F, Zalcman G, Baudrin L, Morin F, Milleron B. [A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]. Rev Mal Respir. 2011 Jan;28(1):51-7.

———————————————————————————————————————————————————

Uhry Z, Hédelin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C,Soler-Michel P, Molinié F, Trétarre B, Rogel A, Courtial I, Danzon A, Guizard AV, Ancelle-Park R, Eilstein D, Duffy S. Modelling the effect of breast cancer screening on related mortality using French data. Cancer Epidemiol. 2011 Jun;35(3):235-42.

———————————————————————————————————————————————————

Zalcman G, Bergot E, Creveuil C, Levallet G, Lechapt E. Integrating biomarkers into clinical trials: methodological issues for a new paradigm in nonsmall cell lung cancer. Curr Opin Oncol. 2011 Jan;23(1):106-11.

———————————————————————————————————————————————————

Zalcman G, Bergot E, Lechapt E. Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting? Lung Cancer. 2011 Apr;72(1):1-2

———————————————————————————————————————————————————

Zigon G, Berrino F, Gatta G, Sánchez MJ, van Dijk B, Van Eycken E, Francisci S; EUROCARE Working Group. Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study. Ann Oncol. 2011 Jan;22(1):165-74.